(March 13, 2024) Overview of Preclinical Small Animal and Multimodal Imaging
Overview:
In this webinar, we reviewed some of the most commonly used preclinical imaging modalities, including magnetic resonance imaging (MRI), positron emission tomography (PET), computer tomography (CT), ultrasound, photoacoustic, bioluminescence, fluorescence, dual-energy x-ray absorptiometry (DEXA/DXA), and intravital microscopy. For each modality, we spent time reviewing the basics of how each worked, the strengths and considerations of each, and some key application areas and example images. Finally, we discussed the benefits of multimodal imaging and reviewed a few papers utilizing a variety of imaging modalities to help support their research outcomes.
We ended with a very brief introduction to Scintica Instrumentation and our philosophy behind the various products we represented. However, the main focus of the webinar was on education, and not our diverse product portfolio.
Key Takeaways:
Understanding Imaging Modalities: We explored a range of preclinical imaging modalities, including MRI, PET, CT, ultrasound, photoacoustic, bioluminescence, fluorescence, DEXA/DXA, and intravital microscopy, providing insights into their mechanisms and functionalities.
Strengths and Considerations: Each imaging modality was analyzed in terms of its strengths and considerations, enabling attendees to grasp the advantages and limitations of each technique.
Application Areas: We highlighted key application areas for each modality, demonstrating their relevance across various research fields and medical domains.
Multimodal Imaging Benefits: The webinar emphasized the benefits of multimodal imaging, showcasing how combining different modalities can provide richer datasets and deeper insights into biological systems.
Research Papers Utilizing Imaging: We reviewed research papers that leveraged multiple imaging modalities to support their findings, illustrating the practical application and importance of integrating various imaging techniques
About the Speaker (s)
Tonya Coulthard,
Tonya Coulthard holds an MSc from the University of British Columbia in Experimental Medicine. Throughout her academic training, she focused on a variety of diseases ranging from prion to chronic obstructive pulmonary diseases. In her professional career, she has worked with several imaging and medical device companies; in these roles, she has interacted with researchers around the world covering a very diverse range of research applications.